Nitric oxide synthase inhibition in migraine

Lancet. 1997 Feb 8;349(9049):401-2. doi: 10.1016/s0140-6736(97)80021-9.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Double-Blind Method
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / physiopathology
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • omega-N-Methylarginine / administration & dosage
  • omega-N-Methylarginine / therapeutic use*

Substances

  • omega-N-Methylarginine
  • Nitric Oxide Synthase